Compare IDA & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IDA | CRL |
|---|---|---|
| Founded | 1915 | 1947 |
| Country | United States | United States |
| Employees | N/A | 19700 |
| Industry | Electric Utilities: Central | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.8B | 7.5B |
| IPO Year | 1998 | 1999 |
| Metric | IDA | CRL |
|---|---|---|
| Price | $136.41 | $151.60 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 13 |
| Target Price | $139.57 | ★ $197.58 |
| AVG Volume (30 Days) | 326.7K | ★ 874.8K |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.52% | N/A |
| EPS Growth | ★ 7.27 | N/A |
| EPS | ★ 5.90 | N/A |
| Revenue | $1,746,972,000.00 | ★ $1,857,601,000.00 |
| Revenue This Year | $10.87 | $2.11 |
| Revenue Next Year | $12.99 | $2.95 |
| P/E Ratio | $23.71 | ★ N/A |
| Revenue Growth | N/A | ★ 10.48 |
| 52 Week Low | $109.30 | $91.86 |
| 52 Week High | $145.94 | $228.88 |
| Indicator | IDA | CRL |
|---|---|---|
| Relative Strength Index (RSI) | 37.53 | 35.37 |
| Support Level | $124.57 | $145.97 |
| Resistance Level | $138.00 | $157.42 |
| Average True Range (ATR) | 2.74 | 6.69 |
| MACD | -0.91 | -0.76 |
| Stochastic Oscillator | 4.30 | 10.53 |
Idacorp Inc is a holding company that, through its subsidiaries, acts as an electric utility engaged in the generation, transmission, distribution, sale, and purchase of electric energy and capacity. The company's only reportable segment is utility operations. The utility operations segment's primary source of revenue is the regulated operations of Idaho Power. The company serves commercial and industrial customers, which are involved in food processing, electronics and general manufacturing, agriculture, health care, government, education, and information technology.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.